title: [Neurohormonal blockade in patients with heart failure at discharge from hospital].
abstract: With the objective to value the degree of fulfillment of the pharmacological processing in patients with heart failure was designed the study of therapeutic adherence in heart failure (ATICA). During the period of inclusion educational, social, demographic data have been obtained, personal antecedents, analytic and physical exploration of the patients. These data mentioned are the ones that are reflected in the present pilot study. The total of patients included is 554, the majority of which are women, the middle ages is advanced and they present a fraction of eyección conserved in more than the half. In the therapeutic plan only was collected information of groups with neurohormonal action and of great recognition in the processing of the heart failure. The most utilized pharmacological group are the IECA, nevertheless medicines as the espirolactona or the betablocker continue showing a worrying degree of infrautilización, although they present a greater prescription that in other series.
authors.affiliation: Servicio de Medicina Interna, Hospital Universitario de La Princesa, Madrid. casadocerrada@hotmail.com
authors.forename: J M
authors.initials: JM
authors.lastname: Casado
authors.forename: E
authors.initials: E
authors.lastname: Visus
authors.forename: J P
authors.initials: JP
authors.lastname: Recio
authors.forename: M
authors.initials: M
authors.lastname: Sánchez-Ledesma
authors.forename: M
authors.initials: M
authors.lastname: Chimeno
authors.forename: B
authors.initials: B
authors.lastname: Roca
authors.forename: P
authors.initials: P
authors.lastname: Conthe
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D010349:Patient Compliance; D010865:Pilot Projects; D011446:Prospective Studies
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists